Начало・Списък с акции・Viatris Inc

Viatris Inc

Затворен

СекторЗдравеопазване

16.25 -0.12

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

16.13

Максимум

16.69

Ключови измерители
By Trading Economics
Приходи	517M 176M
Продажби	-187M 3.5B
EPS	0.59
Дивидентна доходност	2.73
Марж на печалбата	5.016
Служители	30,000
EBITDA	101M 644M

Препоръки
By TipRanks
Препоръки	Неутрален
12-месечна прогноза	+10.59% upside

Дивиденти
By Acuity
Дивидентна доходност Средно за сектора	2.73% 2.29%
Следващи печалби	5.11.2026 г.
Следваща дата на дивидент	16.09.2026 г.
Следваща дата на екс-дивидент	21.08.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	2.8B 21B
Предишно отваряне	16.37
Предишно затваряне	16.25

Viatris Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

10.08.2026 г., 19:42 ч. UTC

Pharmaceuticals sector strength is lifting Viatris Inc during Monday's session, with increased trading volume contributing to the upward movement.

7.08.2026 г., 22:01 ч. UTC

Viatris Inc. shares are higher in after-market trading, supported by a broader equity rally following weaker employment data and reduced interest rate hike concerns.

6.08.2026 г., 23:01 ч. UTC

Viatris Inc shares are higher in after-market hours, recovering from earlier lows. The stock is trading above Thursday's close despite recent declines.

5.08.2026 г., 23:11 ч. UTC

Viatris Inc. shares are trading higher in after-market hours, recovering significantly above the 20-day moving average amid broader market optimism despite no specific news.

4.08.2026 г., 23:06 ч. UTC

Viatris Inc shares are higher in after-market trading, reflecting positive momentum and positioning above the 20-day moving average. No specific news was identified.

3.08.2026 г., 20:06 ч. UTC

Viatris Inc shares are higher today, reflecting broader market gains led by major stocks. The S&P 500 and Nasdaq 100 have also risen.

31.07.2026 г., 21:02 ч. UTC

Viatris Inc shares are lower in after-market hours, continuing a four-session decline amid rising inflation concerns and higher crude oil prices.

30.07.2026 г., 18:56 ч. UTC

Event

Viatris shares are trading lower despite FDA approval of the Gwyn Lo contraceptive patch. Broader economic data may be impacting the stock's performance.

29.07.2026 г., 22:03 ч. UTC

Event

Viatris Inc. shares are lower in after-market hours despite FDA approval of the Gwyn Lo contraceptive patch, amid broader market caution over geopolitical tensions.

28.07.2026 г., 19:36 ч. UTC

Social Media

Viatris shares are higher today, supported by strong sector gains and a significant rise in January 2027 $10 call options activity.

27.07.2026 г., 19:11 ч. UTC

Viatris Inc shares are higher today, breaking a trend of daily gains. No specific news was identified to explain this movement.

23.07.2026 г., 20:06 ч. UTC

Viatris Inc's shares are higher during Thursday's session, continuing an upward trend since Wednesday's close. No specific news was identified to explain the movement.

22.07.2026 г., 23:16 ч. UTC

Viatris Inc shares are higher in after-market hours, recovering from an earlier dip and reflecting strength amid rising crude oil prices.

21.07.2026 г., 18:46 ч. UTC

Viatris Inc shares are higher today, rebounding after an earlier dip amid a broader recovery in U.S. markets and renewed investor optimism.

20.07.2026 г., 19:21 ч. UTC

News

Viatris Inc shares are lower amid negative sentiment in the Pharmaceuticals sector. Analysts cite a price target of $17.81, reflecting concerns over sales declines.

Сравнение с други в отрасъла

Ценова промяна

Viatris Inc Прогноза

Ценова цел

By TipRanks

10.59% нагоре

12-месечна прогноза

Среден 18.17 USD 10.59%

Висок 23 USD

Нисък 12 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Viatris Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

6 ratings

Купи

Задържане

Продай

Според 6 анализатори, дали борсови рейтинги на Viatris Inc през последните 3 месеца.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Viatris Inc

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.